1. Home
  2. STTK vs VMD Comparison

STTK vs VMD Comparison

Compare STTK & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.18

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

HOLD

Current Price

$8.63

Market Cap

313.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
VMD
Founded
2016
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
313.3M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
STTK
VMD
Price
$6.18
$8.63
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
617.5K
318.8K
Earning Date
03-05-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
32.14
EPS
N/A
0.37
Revenue
$1,000,000.00
$270,280,000.00
Revenue This Year
N/A
$24.27
Revenue Next Year
N/A
$15.47
P/E Ratio
N/A
$24.96
Revenue Growth
N/A
20.52
52 Week Low
$0.69
$5.93
52 Week High
$6.27
$10.06

Technical Indicators

Market Signals
Indicator
STTK
VMD
Relative Strength Index (RSI) 73.59 46.66
Support Level $1.85 $7.93
Resistance Level N/A $8.94
Average True Range (ATR) 0.42 0.51
MACD 0.05 -0.06
Stochastic Oscillator 93.80 39.24

Price Performance

Historical Comparison
STTK
VMD

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Share on Social Networks: